The department was among the country’s earliest to offer doctoral program in obstetrics and gynecology. The discipline was listed in the second batch of national key disciplines and the first batch of national key clinical specialties. Ranked in China’s top 10, it played a key role in editing in chief the national-planned textbook Obstetrics and Gynecology, and in sponsoring Progress in Obstetrics and Gynecology, one of China’s core journals.

The team consists of 120 obstetricians and gynecologists who are specialized in gynecological oncology, general gynecology, family planning, perinatal medicine and reproductive medicine, with gynecological oncology being a national key discipline. Clinically, it treats about 1,500 female patients with malignant tumours in primary management every year — five-year survival rate for ovarian cancer at 50% recently— which is on the higher level in the world. It has set Diagnosis Criteria for Cervical Cancer, the national health standard, for the National Health Commission (NHC), and has led the development of several guidelines and expert consensus documents for the diagnosis and treatment of gynecologic oncology. It also established the world’s first ultra-fast approach to identifying cervical lesions.

The focal points of its research include the pathogenesis, early diagnosis and comprehensive therapy of gynecological tumors. It has suggested several innovative theories, such as ‘low-grade serous ovarian carcinoma originating from oviducts’, which is included in national-planned textbooks on obstetrics and gynecology as well as guidelines for the diagnosis and treatment of gynecological tumors. In the last decade, it has undertaken more than 100 national-level research projects, leading to over 200 international publications and 30 national invention patents. 

The department has Key Laboratory of Gynecological Cancer in Shandong University and "Taishan Scholar Climbing Plan" in Shandong Province. In recent years, the discipline has undertaken 51 national scientific research projects, won 13 awards for scientific and technological progress, formulated one industry diagnosis and treatment standard of the Ministry of Health for major diseases, and published 350 SCI papers.We have established long-term substantive cooperation with the United States, Japan, Canada, Sweden and more than 10 high-level medical colleges and universities.